Commentaries
Imatinib: A New Tool for the Management of Chronic Sclerodermatous Graft-vs-Host Disease
Imatinib: Una nueva herramienta para el manejo de la enfermedad del injerto contra el hospedador crónica esclerodermiforme
C. Ferrándiz-Pulido
Servicio de Dermatología, Hospital Universitario Vall d’Hebron, Barcelona Sección: Comentario Editorial
Leído
4528
Vecesse ha leído el artículo
1894
Total PDF
2634
Total HTML
Compartir estadísticas
array:24 [ "pii" => "S1578219018300398" "issn" => "15782190" "doi" => "10.1016/j.adengl.2018.02.022" "estado" => "S300" "fechaPublicacion" => "2018-04-01" "aid" => "1878" "copyright" => "Elsevier España, S.L.U. and AEDV" "copyrightAnyo" => "2018" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Actas Dermosifiliogr. 2018;109:200-1" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 63 "formatos" => array:2 [ "HTML" => 62 "PDF" => 1 ] ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0001731017306750" "issn" => "00017310" "doi" => "10.1016/j.ad.2017.12.002" "estado" => "S300" "fechaPublicacion" => "2018-04-01" "aid" => "1878" "copyright" => "AEDV" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Actas Dermosifiliogr. 2018;109:200-1" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 117 "formatos" => array:2 [ "HTML" => 91 "PDF" => 26 ] ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Comentario editorial</span>" "titulo" => "Imatinib: una nueva herramienta para el manejo de la enfermedad del injerto contra el hospedador crónica esclerodermiforme" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "200" "paginaFinal" => "201" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Imatinib: A New Tool for the Management of Chronic Sclerodermatous Graft-Vs-Host Disease" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "C. Ferrándiz-Pulido" "autores" => array:1 [ 0 => array:2 [ "nombre" => "C." "apellidos" => "Ferrándiz-Pulido" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1578219018300398" "doi" => "10.1016/j.adengl.2018.02.022" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219018300398?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731017306750?idApp=UINPBA000044" "url" => "/00017310/0000010900000003/v1_201804020403/S0001731017306750/v1_201804020403/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S1578219018300052" "issn" => "15782190" "doi" => "10.1016/j.adengl.2018.02.003" "estado" => "S300" "fechaPublicacion" => "2018-04-01" "aid" => "1827" "copyright" => "Elsevier España, S.L.U. and AEDV" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Actas Dermosifiliogr. 2018;109:202-6" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 61 "HTML" => 61 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Opinion Article</span>" "titulo" => "Translation and Cross-Cultural Adaptation of Health Assessment Tools" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "202" "paginaFinal" => "206" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Proceso de traducción y adaptación cultural de instrumentos de medición en salud" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1501 "Ancho" => 3082 "Tamanyo" => 250606 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Steps in the translation and cultural adaptation of a clinical measurement tool. Adapted from Beaton et al.<a class="elsevierStyleCrossRef" href="#bib0125"><span class="elsevierStyleSup">9</span></a></p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "S. Ortiz-Gutiérrez, A. Cruz-Avelar" "autores" => array:2 [ 0 => array:2 [ "nombre" => "S." "apellidos" => "Ortiz-Gutiérrez" ] 1 => array:2 [ "nombre" => "A." "apellidos" => "Cruz-Avelar" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0001731017305616" "doi" => "10.1016/j.ad.2017.09.012" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731017305616?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219018300052?idApp=UINPBA000044" "url" => "/15782190/0000010900000003/v1_201804020430/S1578219018300052/v1_201804020430/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S1578219018300209" "issn" => "15782190" "doi" => "10.1016/j.adengl.2018.02.018" "estado" => "S300" "fechaPublicacion" => "2018-04-01" "aid" => "1857" "copyright" => "Elsevier España, S.L.U. and AEDV" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Actas Dermosifiliogr. 2018;109:200" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 65 "formatos" => array:2 [ "HTML" => 63 "PDF" => 2 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Commentaries</span>" "titulo" => "Imiquimoid 5%: In Pursuit of New Treatment Regimens for Actinic Keratosis" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "200" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Búsqueda de nuevas pautas terapéuticas de imiquimod 5% para el tratamiento de las queratosis actínicas" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "R. Salido Vallejo" "autores" => array:1 [ 0 => array:2 [ "nombre" => "R." "apellidos" => "Salido Vallejo" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0001731017306282" "doi" => "10.1016/j.ad.2017.11.005" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731017306282?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219018300209?idApp=UINPBA000044" "url" => "/15782190/0000010900000003/v1_201804020430/S1578219018300209/v1_201804020430/en/main.assets" ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Commentaries</span>" "titulo" => "Imatinib: A New Tool for the Management of Chronic Sclerodermatous Graft-vs-Host Disease" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "200" "paginaFinal" => "201" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "C. Ferrándiz-Pulido" "autores" => array:1 [ 0 => array:3 [ "nombre" => "C." "apellidos" => "Ferrándiz-Pulido" "email" => array:1 [ 0 => "40879cfp@comb.cat" ] ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Servicio de Dermatología, Hospital Universitario Vall d’Hebron, Barcelona Sección: Comentario Editorial" "identificador" => "aff0005" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Imatinib: Una nueva herramienta para el manejo de la enfermedad del injerto contra el hospedador crónica esclerodermiforme" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">The therapeutic management of chronic sclerodermatous graft-vs-host disease (GVHD) is challenging because, apart from systemic corticosteroids, no treatments have shown clear benefits in terms of long-term effectiveness or tolerability. In this retrospective study, the authors describe their experience with the use of imatinib to treat chronic sclerodermatous GVHD in 18 patients who did not respond to systemic corticosteroids. The majority of patients (83%) responded at least partially and the treatment also permitted corticosteroid tapering in a high proportion of cases (78%). Imatinib is a potent tyrosine-kinase inhibitor that is used in GVHD because of its dual inhibitory activity against platelet-derived growth factor receptor and transforming growth factor-β. There is no evidence from clinical trials to support the use of imatinib in chronic sclerodermatous GVHD. This study, however, adds to data from other series in which imatinib has improved symptoms and achieved response rates of between 50% and 79%, with lower rates observed in older patients and patients with more advanced lung disease.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> Imatinib is also a relatively well-tolerated drug associated with low levels of discontinuation due to adverse effects. Despite the retrospective nature of this study, its results add to the body of evidence on the effectiveness of imatinib in the management of chronic sclerodermatous GVHD. Prospective studies, however, are needed to confirm these preliminary results.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Ferrándiz-Pulido C. matinib: una nueva herramienta para el manejo de la enfermedad del injerto contra el hospedador crónica esclerodermiforme. Actas Dermosifiliogr. 2018;109:200–201.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "Reference" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:1 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treatment of chronic graft-versus-host disease in 2011" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "Y. Inamoto" 1 => "M.E.D. Flowers" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/MOH.0b013e32834ba87d" "Revista" => array:6 [ "tituloSerie" => "Curr Opin Hematol." "fecha" => "2011" "volumen" => "18" "paginaInicial" => "414" "paginaFinal" => "420" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21912257" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/15782190/0000010900000003/v1_201804020430/S1578219018300398/v1_201804020430/en/main.assets" "Apartado" => array:4 [ "identificador" => "66476" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Commentaries" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/15782190/0000010900000003/v1_201804020430/S1578219018300398/v1_201804020430/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219018300398?idApp=UINPBA000044" ]
| año/Mes | Html | Total | |
|---|---|---|---|
| 2024 Noviembre | 14 | 11 | 25 |
| 2024 Octubre | 77 | 37 | 114 |
| 2024 Septiembre | 65 | 20 | 85 |
| 2024 Agosto | 105 | 38 | 143 |
| 2024 Julio | 71 | 33 | 104 |
| 2024 Junio | 94 | 21 | 115 |
| 2024 Mayo | 62 | 26 | 88 |
| 2024 Abril | 79 | 27 | 106 |
| 2024 Marzo | 75 | 26 | 101 |
| 2024 Febrero | 59 | 27 | 86 |
| 2024 Enero | 57 | 28 | 85 |
| 2023 Diciembre | 70 | 16 | 86 |
| 2023 Noviembre | 71 | 25 | 96 |
| 2023 Octubre | 57 | 27 | 84 |
| 2023 Septiembre | 67 | 26 | 93 |
| 2023 Agosto | 33 | 15 | 48 |
| 2023 Julio | 42 | 32 | 74 |
| 2023 Junio | 61 | 21 | 82 |
| 2023 Mayo | 40 | 20 | 60 |
| 2023 Abril | 46 | 22 | 68 |
| 2023 Marzo | 56 | 39 | 95 |
| 2023 Febrero | 32 | 25 | 57 |
| 2023 Enero | 41 | 41 | 82 |
| 2022 Diciembre | 42 | 49 | 91 |
| 2022 Noviembre | 14 | 31 | 45 |
| 2022 Octubre | 17 | 20 | 37 |
| 2022 Septiembre | 21 | 37 | 58 |
| 2022 Agosto | 28 | 29 | 57 |
| 2022 Julio | 24 | 30 | 54 |
| 2022 Junio | 21 | 24 | 45 |
| 2022 Mayo | 36 | 34 | 70 |
| 2022 Abril | 46 | 38 | 84 |
| 2022 Marzo | 44 | 58 | 102 |
| 2022 Febrero | 32 | 27 | 59 |
| 2022 Enero | 33 | 53 | 86 |
| 2021 Diciembre | 32 | 52 | 84 |
| 2021 Noviembre | 45 | 56 | 101 |
| 2021 Octubre | 43 | 64 | 107 |
| 2021 Septiembre | 27 | 40 | 67 |
| 2021 Agosto | 26 | 39 | 65 |
| 2021 Julio | 30 | 31 | 61 |
| 2021 Junio | 32 | 25 | 57 |
| 2021 Mayo | 36 | 57 | 93 |
| 2021 Abril | 94 | 101 | 195 |
| 2021 Marzo | 73 | 49 | 122 |
| 2021 Febrero | 57 | 51 | 108 |
| 2021 Enero | 45 | 48 | 93 |
| 2020 Diciembre | 43 | 47 | 90 |
| 2020 Noviembre | 26 | 30 | 56 |
| 2020 Octubre | 31 | 17 | 48 |
| 2020 Septiembre | 31 | 25 | 56 |
| 2020 Agosto | 35 | 31 | 66 |
| 2020 Julio | 32 | 22 | 54 |
| 2020 Junio | 41 | 34 | 75 |
| 2020 Mayo | 10 | 13 | 23 |
| 2020 Abril | 21 | 19 | 40 |
| 2020 Marzo | 30 | 9 | 39 |
| 2020 Enero | 4 | 0 | 4 |
| 2019 Diciembre | 10 | 0 | 10 |
| 2019 Noviembre | 5 | 0 | 5 |
| 2019 Septiembre | 10 | 0 | 10 |
| 2019 Agosto | 2 | 0 | 2 |
| 2019 Julio | 6 | 0 | 6 |
| 2019 Junio | 4 | 0 | 4 |
| 2019 Mayo | 6 | 0 | 6 |
| 2019 Abril | 2 | 0 | 2 |
| 2019 Marzo | 2 | 0 | 2 |
| 2019 Febrero | 2 | 0 | 2 |
| 2018 Diciembre | 2 | 0 | 2 |
| 2018 Noviembre | 3 | 0 | 3 |
| 2018 Octubre | 1 | 0 | 1 |
| 2018 Septiembre | 1 | 0 | 1 |
| 2018 Abril | 2 | 0 | 2 |
| 2018 Marzo | 0 | 1 | 1 |
Mostrar todo
